{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T12:36:08Z","timestamp":1794400568440,"version":"4.9.0"},"reference-count":259,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32-CA082088"],"award-info":[{"award-number":["T32-CA082088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5R01-CA240991"],"award-info":[{"award-number":["5R01-CA240991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K22-CA234400"],"award-info":[{"award-number":["K22-CA234400"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009429","name":"Israel National Road Safety Authority","doi-asserted-by":"publisher","award":["5R01-CA240991"],"award-info":[{"award-number":["5R01-CA240991"]}],"id":[{"id":"10.13039\/100009429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009429","name":"Israel National Road Safety Authority","doi-asserted-by":"publisher","award":["T32-CA082088"],"award-info":[{"award-number":["T32-CA082088"]}],"id":[{"id":"10.13039\/100009429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.eururo.2023.04.021","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T22:49:54Z","timestamp":1684277394000},"page":"191-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":842,"title":["2022 Update on Prostate Cancer Epidemiology and Risk Factors\u2014A Systematic Review"],"prefix":"10.1016","volume":"84","author":[{"given":"Oskar","family":"Bergengren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Pekala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Matsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Fainberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean F.","family":"Mungovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otis","family":"Brawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy N.","family":"Luckenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid V.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2023.04.021_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2023.04.021_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0025","unstructured":"Ferlay J, Laversanne M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020. https:\/\/gco.iarc.fr\/today."},{"key":"10.1016\/j.eururo.2023.04.021_b0030","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2023.04.021_b0035","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2023.04.021_b0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MOU.0000000000000951","article-title":"Why do African-American men face higher risks for lethal prostate cancer?","volume":"32","author":"Nair","year":"2022","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2019.09.058","article-title":"Health care disparities in urologic oncology: a systematic review","volume":"136","author":"Das","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.021_b0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-12-418","article-title":"Spatial distribution of G6PD deficiency variants across malaria-endemic regions","volume":"12","author":"Howes","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.eururo.2023.04.021_b0055","first-page":"562","article-title":"Geographic and ethnic distributions of the more frequent cystic fibrosis mutations in Europe show that a founder effect is apparent for several mutant alleles","volume":"67","author":"Lucotte","year":"1995","journal-title":"Hum Biol"},{"key":"10.1016\/j.eururo.2023.04.021_b0060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajpa.23120","article-title":"Anthropologists' views on race, ancestry, and genetics","volume":"162","author":"Wagner","year":"2017","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.eururo.2023.04.021_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.prnil.2019.08.001","article-title":"A review of social determinants of prostate cancer risk, stage, and survival","volume":"8","author":"Coughlin","year":"2020","journal-title":"Prostate Int"},{"key":"10.1016\/j.eururo.2023.04.021_b0070","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00345-016-1953-9","article-title":"National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis","volume":"35","author":"Neupane","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2022.03.007","article-title":"Deconstructing, addressing, and eliminating racial and ethnic inequities in prostate cancer care","volume":"82","author":"Nyame","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0306312710379170","article-title":"Different differences: the use of 'genetic ancestry' versus race in biomedical human genetic research","volume":"41","author":"Fujimura","year":"2011","journal-title":"Soc Stud Sci"},{"key":"10.1016\/j.eururo.2023.04.021_b0085","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMc2000069","article-title":"Racial differences in genomic profiling of prostate cancer","volume":"383","author":"Mahal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0090","doi-asserted-by":"crossref","first-page":"e155031","DOI":"10.1172\/JCI155031","article-title":"Health inequity drives disease biology to create disparities in prostate cancer outcomes","volume":"132","author":"Nelson","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eururo.2023.04.021_b0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of Black race with prostate cancer-specific and other-cause mortality","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0100","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/cncr.33643","article-title":"Interaction between race and prostate cancer treatment benefit in the Veterans Health Administration","volume":"127","author":"Rude","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cncr.33224","article-title":"Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration","volume":"127","author":"McKay","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0110","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/cncr.33152","article-title":"Racial disparities in mortality for patients with prostate cancer after radical prostatectomy","volume":"127","author":"Wen","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0115","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/1471-0528.15258","article-title":"Breast and reproductive cancers in the transgender population: a systematic review","volume":"125","author":"Joint","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.eururo.2023.04.021_b0120","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/cen.13835","article-title":"Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals\u2014a systematic review","volume":"89","author":"McFarlane","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eururo.2023.04.021_b0125","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.21037\/tau-20-954","article-title":"Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model","volume":"9","author":"Sterling","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0130","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/jnci\/djt151","article-title":"Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men","volume":"105","author":"Zlotta","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2023.04.021_b0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eururo.2021.12.011","article-title":"Defining the impact of family history on detection of high-grade prostate cancer in a large multi-institutional cohort","volume":"82","author":"Clements","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1464-410X.2003.04232.x","article-title":"A systematic review and meta-analysis of familial prostate cancer risk","volume":"91","author":"Johns","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.021_b0145","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2012.02.032","article-title":"Concordance of tumor differentiation among brothers with prostate cancer","volume":"62","author":"Jansson","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0150","doi-asserted-by":"crossref","first-page":"djw110","DOI":"10.1093\/jnci\/djw110","article-title":"Family history and probability of prostate cancer, differentiated by risk category: a nationwide population-based study","volume":"108","author":"Bratt","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2023.04.021_b0155","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1186\/s12885-019-6055-9","article-title":"First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2022.11.019","article-title":"Family history of prostate cancer and survival outcomes in the UK Genetic Prostate Cancer Study","volume":"83","author":"Brook","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2023.04.021_b0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0175","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-021-01675-5","article-title":"BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis","volume":"126","author":"Nyberg","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0185","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2018.11.015","article-title":"Homeobox B13 G84E mutation and prostate cancer risk","volume":"75","author":"Nyberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0190","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.euo.2020.12.001","article-title":"Rare germline variants in ATM predispose to prostate cancer: a PRACTICAL consortium study","volume":"4","author":"Karlsson","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0200","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S1470-2045(21)00522-2","article-title":"A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study","volume":"22","author":"Bancroft","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2020.11.014","article-title":"Performance of three inherited risk measures for predicting prostate cancer incidence and mortality: a population-based prospective analysis","volume":"79","author":"Shi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41698-022-00266-8","article-title":"Prostate cancer polygenic risk score and prediction of lethal prostate cancer","volume":"6","author":"Klein","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0215","doi-asserted-by":"crossref","first-page":"316.e1","DOI":"10.1016\/j.clgc.2022.09.006","article-title":"How well do polygenic risk scores identify men at high risk for prostate cancer? Systematic review and meta-analysis","volume":"21","author":"Siltari","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0220","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jnci\/djac199","article-title":"Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program","volume":"115","author":"Pagadala","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2023.04.021_b0225","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","article-title":"Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci","volume":"50","author":"Schumacher","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2023.04.021_b0230","doi-asserted-by":"crossref","first-page":"e78304","DOI":"10.7554\/eLife.78304","article-title":"Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: a meta-analysis within diverse populations","volume":"11","author":"Chen","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.eururo.2023.04.021_b0235","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1200\/JCO.22.01453","article-title":"CanRisk-Prostate: a comprehensive, externally validated risk model for the prediction of future prostate cancer","volume":"41","author":"Nyberg","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0240","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/jnci\/djab058","article-title":"Evaluation of a multiethnic polygenic risk score model for prostate cancer","volume":"114","author":"Plym","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2023.04.021_b0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.eururo.2022.05.008","article-title":"A healthy lifestyle in men at increased genetic risk for prostate cancer","volume":"83","author":"Plym","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0250","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41391-021-00458-6","article-title":"Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies","volume":"25","author":"Xu","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12885-018-4194-z","article-title":"Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis","volume":"18","author":"Liang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0260","doi-asserted-by":"crossref","first-page":"80.e7","DOI":"10.1016\/j.urolonc.2017.09.022","article-title":"Association between male pattern baldness and prostate disease: a meta-analysis","volume":"36","author":"Jin","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0265","first-page":"13179","article-title":"The relationship between male pattern baldness and prostate cancer risk: a meta-analysis","volume":"12","author":"Zhao","year":"2019","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0270","doi-asserted-by":"crossref","first-page":"e11379","DOI":"10.1097\/MD.0000000000011379","article-title":"Male pattern baldness and incidence of prostate cancer: a systematic review and meta-analysis","volume":"97","author":"He","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b0275","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/bjc.2017.231","article-title":"Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium","volume":"117","author":"Lophatananon","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0280","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/1940-6207.CAPR-19-0271","article-title":"Sedentary behavior and prostate cancer: a systematic review and meta-analysis of prospective cohort studies","volume":"12","author":"Berger","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.eururo.2023.04.021_b0285","doi-asserted-by":"crossref","unstructured":"Garcia L, Pearce M, Abbas A, et al. Non-occupational physical activity and risk of 22 cardiovascular disease, cancer, and mortality outcomes: a dose-response meta-analysis of large prospective studies. Br J Sports Med. In press. https:\/\/doi.org\/10.1136\/bjsports-2022-105669.","DOI":"10.1136\/bjsports-2022-105669"},{"key":"10.1016\/j.eururo.2023.04.021_b0290","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1249\/MSS.0000000000001937","article-title":"Physical activity in cancer prevention and survival: a systematic review","volume":"51","author":"McTiernan","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.eururo.2023.04.021_b0295","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/annonc\/mdy073","article-title":"Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis","volume":"29","author":"Benke","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0300","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/1055-9965.EPI-20-0870","article-title":"Associations of leisure-time physical activity and television viewing with life expectancy cancer-free at age 50: the ARIC study","volume":"29","author":"Cuthbertson","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b0305","doi-asserted-by":"crossref","first-page":"e21180","DOI":"10.1097\/MD.0000000000021180","article-title":"The association between sleep duration and prostate cancer: A systematic review and meta-analysis","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b0310","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1055-9965.EPI-12-0116","article-title":"Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies","volume":"21","author":"Sigurdardottir","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b0315","doi-asserted-by":"crossref","first-page":"e16341","DOI":"10.1097\/MD.0000000000016341","article-title":"Mediterranean dietary pattern and the risk of prostate cancer: a meta-analysis","volume":"98","author":"Cheng","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b0320","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/nu9101063","article-title":"Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis","volume":"9","author":"Schwingshackl","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.eururo.2023.04.021_b0325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12916-022-02257-9","article-title":"Association of meat, vegetarian, pescatarian and fish-poultry diets with risk of 19 cancer sites and all cancer: findings from the UK Biobank prospective cohort study and meta-analysis","volume":"20","author":"Parra-Soto","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0330","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41391-022-00553-2","article-title":"Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes","volume":"25","author":"Gupta","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jhn.12426","article-title":"Vegetarianism and breast, colorectal and prostate cancer risk: an overview and meta-analysis of cohort studies","volume":"30","author":"Godos","year":"2017","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.eururo.2023.04.021_b0340","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1017\/S1368980013002115","article-title":"Designing and developing a literature-derived, population-based dietary inflammatory index","volume":"17","author":"Shivappa","year":"2014","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0345","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.nut.2018.04.018","article-title":"Associations between dietary inflammatory index and incidence of breast and prostate cancer: a systematic review and meta-analysis","volume":"55\u201356","author":"Moradi","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.eururo.2023.04.021_b0350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/01635581.2018.1516787","article-title":"Association between dietary inflammatory index and the risk of prostate cancer: a meta-analysis","volume":"71","author":"Mohseni","year":"2019","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0355","doi-asserted-by":"crossref","first-page":"e0204845","DOI":"10.1371\/journal.pone.0204845","article-title":"Meta-analysis of the association between the inflammatory potential of diet and urologic cancer risk","volume":"13","author":"Lu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2023.04.021_b0360","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/advances\/nmy015","article-title":"Dietary inflammatory index and site-specific cancer risk: a systematic review and dose-response meta-analysis","volume":"9","author":"Jayedi","year":"2018","journal-title":"Adv Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0365","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41430-019-0500-3","article-title":"Dietary inflammatory index and the risk of prostate cancer: a dose-response meta-analysis","volume":"74","author":"Zhu","year":"2020","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0370","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2020.12.030","article-title":"Insulinemic and inflammatory dietary patterns and risk of prostate cancer","volume":"79","author":"Fu","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0375","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1158\/1055-9965.EPI-22-0147","article-title":"Postdiagnostic inflammatory, hyperinsulinemic, and insulin-resistant diets and lifestyles and the risk of prostate cancer progression and mortality","volume":"31","author":"Langlais","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b0380","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12957-018-1452-0","article-title":"Association between dietary protein intake and prostate cancer risk: evidence from a meta-analysis","volume":"16","author":"Mao","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0385","article-title":"Dietary protein intake and prostate cancer risk in adults: a systematic review and dose-response meta-analysis of prospective cohort studies","volume":"70","author":"Al-Zahrani","year":"2022","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13020516","article-title":"Consumption of sweet beverages and cancer risk. A systematic review and meta-analysis of observational studies","volume":"13","author":"Llaha","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.eururo.2023.04.021_b0395","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.7150\/jca.51322","article-title":"Consumption of sugar-sweetened beverages and fruit juice and human cancer: a systematic review and dose-response meta-analysis of observational studies","volume":"12","author":"Li","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0400","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2018.05.032","article-title":"Carbohydrate intake and the risk of prostate cancer","volume":"484","author":"Fan","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.eururo.2023.04.021_b0405","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3390\/nu11102342","article-title":"Glycemic index, glycemic load and cancer risk: an updated meta-analysis","volume":"11","author":"Turati","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.eururo.2023.04.021_b0410","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/01635581.2019.1621356","article-title":"Dietary Glycemic Index and glycemic load and the risk of prostate cancer: an updated systematic review and dose-response meta-analysis","volume":"72","author":"Sadeghi","year":"2020","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clnesp.2021.02.008","article-title":"Dietary glycemic index, glycemic load, insulin index, insulin load and risk of diabetes-related cancers: a systematic review of cohort studies","volume":"42","author":"Hatami Marbini","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.eururo.2023.04.021_b0420","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/nutrit\/nuaa061","article-title":"Dietary trans-fatty acid intake in relation to cancer risk: a systematic review and meta-analysis","volume":"79","author":"Michels","year":"2021","journal-title":"Nutr Rev"},{"key":"10.1016\/j.eururo.2023.04.021_b0425","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/01635581.2021.1952445","article-title":"Fruit and vegetable consumption and the risk of prostate cancer: a systematic review and meta-analysis","volume":"74","author":"Yan","year":"2022","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0430","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41391-022-00570-1","article-title":"Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis","volume":"25","author":"Cirne","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.129697","article-title":"Red and processed meat consumption and cancer outcomes: umbrella review","volume":"356","author":"Huang","year":"2021","journal-title":"Food Chem"},{"key":"10.1016\/j.eururo.2023.04.021_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.801722","article-title":"Association between red and processed meat consumption and risk of prostate cancer: a systematic review and meta-analysis","volume":"9","author":"Nouri-Majd","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0445","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/M19-0699","article-title":"Reduction of red and processed meat intake and cancer mortality and incidence a systematic review and meta-analysis of cohort studies","volume":"171","author":"Han","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0450","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10654-021-00741-9","article-title":"Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies","volume":"36","author":"Farvid","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.eururo.2023.04.021_b0455","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/09637486.2022.2050996","article-title":"Total, red and processed meat consumption and human health: an umbrella review of observational studies","volume":"73","author":"Grosso","year":"2022","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0460","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1534735416656052","article-title":"Fish-derived omega-3 fatty acids and prostate cancer: a systematic review","volume":"16","author":"Aucoin","year":"2017","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.eururo.2023.04.021_b0465","first-page":"9891","article-title":"Fish consumption and prostate cancer risk: a meta-analysis of 37 studies","volume":"10","author":"Dai","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0470","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/nu13020384","article-title":"Association of the omega-3 index with incident prostate cancer with updated meta-analysis: the Cooper Center Longitudinal Study","volume":"13","author":"Farrell","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.eururo.2023.04.021_b0475","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12986-020-00527-y","article-title":"Milk consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses in humans","volume":"18","author":"Zhang","year":"2021","journal-title":"Nutr Metab"},{"key":"10.1016\/j.eururo.2023.04.021_b0480","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/nutrit\/nuaa013","article-title":"Yogurt, cultured fermented milk, and health: a systematic review","volume":"79","author":"Savaiano","year":"2021","journal-title":"Nutr Rev"},{"key":"10.1016\/j.eururo.2023.04.021_b0485","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5534\/wjmh.200051","article-title":"Milk consumption and prostate cancer: a systematic review","volume":"39","author":"Sargsyan","year":"2021","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2023.04.021_b0490","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1093\/advances\/nmz014","article-title":"Milk and dairy product consumption and prostate cancer risk and mortality: an overview of systematic reviews and meta-analyses","volume":"10","author":"L\u00f3pez-Plaza","year":"2019","journal-title":"Adv Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0495","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/advances\/nmab135","article-title":"Dairy consumption and total cancer and cancer-specific mortality: a meta-analysis of prospective cohort studies","volume":"13","author":"Jin","year":"2022","journal-title":"Adv Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0500","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/pcan.2017.25","article-title":"Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis","volume":"20","author":"Rowles","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0505","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41391-017-0005-x","article-title":"Processed and raw tomato consumption and risk of prostate cancer: a systematic review and dose-response meta-analysis","volume":"21","author":"Rowles","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128396","article-title":"Tomato and lycopene and multiple health outcomes: umbrella review","volume":"343","author":"Li","year":"2021","journal-title":"Food Chem"},{"key":"10.1016\/j.eururo.2023.04.021_b0515","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.625185","article-title":"Dietary tomato consumption and the risk of prostate cancer: a meta-analysis","volume":"8","author":"Luo","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0520","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/09637486.2016.1216525","article-title":"Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies","volume":"68","author":"Zhang","year":"2017","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0525","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/nu10010040","article-title":"Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis","volume":"10","author":"Applegate","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.eururo.2023.04.021_b0530","doi-asserted-by":"crossref","first-page":"44776","DOI":"10.18632\/oncotarget.16794","article-title":"Legume intake and risk of prostate cancer: a meta-analysis of prospective cohort studies","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2023.04.021_b0535","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.31640","article-title":"Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls","volume":"143","author":"Perez-Cornago","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0540","doi-asserted-by":"crossref","first-page":"e6426","DOI":"10.1097\/MD.0000000000006426","article-title":"Green tea and the risk of prostate cancer: a systematic review and meta-analysis","volume":"96","author":"Guo","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.eururo.2023.04.021_b0545","article-title":"Green tea (Camellia sinensis) for the prevention of cancer","volume":"3","author":"Filippini","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2023.04.021_b0550","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-nutr-071816-064941","article-title":"Coffee, caffeine, and health outcomes: an umbrella review","volume":"37","author":"Grosso","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0555","doi-asserted-by":"crossref","first-page":"e038902","DOI":"10.1136\/bmjopen-2020-038902","article-title":"Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Chen","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2023.04.021_b0560","first-page":"4079","article-title":"An up-to-date meta-analysis of coffee consumption and risk of prostate cancer","volume":"14","author":"Xia","year":"2017","journal-title":"Urol J"},{"key":"10.1016\/j.eururo.2023.04.021_b0565","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ijc.31634","article-title":"Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition","volume":"144","author":"Sen","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0570","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/nu12082188","article-title":"Alcohol consumption and the risk of prostate cancer: a dose-response meta-analysis","volume":"12","author":"Hong","year":"2020","journal-title":"Nutrients."},{"key":"10.1016\/j.eururo.2023.04.021_b0575","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/CLEP.S163668","article-title":"The impact of moderate wine consumption on the risk of developing prostate cancer","volume":"10","author":"Vartolomei","year":"2018","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.eururo.2023.04.021_b0580","first-page":"32","article-title":"The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis","volume":"46","author":"Waziry","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eururo.2023.04.021_b0585","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2014.08.059","article-title":"A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies","volume":"66","author":"Islami","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0590","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1001\/jama.2011.879","article-title":"Smoking and prostate cancer survival and recurrence","volume":"305","author":"Kenfield","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2023.04.021_b0595","doi-asserted-by":"crossref","first-page":"19","DOI":"10.18332\/tid\/157231","article-title":"Cigarette smoking and prostate cancer: a systematic review and meta-analysis of prospective cohort studies","volume":"21","author":"Al-Fayez","year":"2023","journal-title":"Tob Induc Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0600","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijmr.IJMR_2023_17","article-title":"Relationship between type of smokeless tobacco & risk of cancer: a systematic review","volume":"148","author":"Gupta","year":"2018","journal-title":"Indian J Med Res Suppl"},{"key":"10.1016\/j.eururo.2023.04.021_b0605","first-page":"10768","article-title":"Male circumcision and prostate cancer: a meta-analysis revisited","volume":"28","author":"Morris","year":"2021","journal-title":"Can J Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0610","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.fertnstert.2020.04.042","article-title":"Association between male infertility and male-specific malignancies: systematic review and meta-analysis of population-based retrospective cohort studies","volume":"114","author":"Del Giudice","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eururo.2023.04.021_b0615","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4111\/icu.2020.61.4.355","article-title":"Clinical correlation among male infertility and overall male health: a systematic review of the literature","volume":"61","author":"Del Giudice","year":"2020","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0620","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MOU.0000000000000886","article-title":"Association between male infertility and prostate cancer: a systematic review and meta-analysis","volume":"31","author":"Laukhtina","year":"2021","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0625","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.696702","article-title":"A systematic review and meta-analysis of male infertility and the subsequent risk of cancer","volume":"11","author":"Behboudi-Gandevani","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0630","first-page":"2978","article-title":"Does vasectomy increase prostate cancer risk? An updated meta-analysis and systematic review of cohort studies","volume":"11","author":"Wu","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0635","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/carcin\/bgaa086","article-title":"Vasectomy and prostate cancer risk: a meta-analysis of prospective studies","volume":"42","author":"Cheng","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.eururo.2023.04.021_b0640","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamainternmed.2017.2791","article-title":"The association between vasectomy and prostate cancer: a systematic review and meta-analysis","volume":"177","author":"Bhindi","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0645","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euros.2022.04.012","article-title":"Vasectomy and risk of prostate cancer: a systematic review and meta-analysis","volume":"41","author":"Baboudjian","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2023.04.021_b0650","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41391-021-00368-7","article-title":"Association between vasectomy and risk of prostate cancer: a meta-analysis","volume":"24","author":"Xu","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0655","first-page":"4798","article-title":"Does prostatitis increase the risk of prostate cancer? A meta-analysis","volume":"10","author":"Ding","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0660","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4081\/aiua.2017.4.259","article-title":"The association between prostatitis and prostate cancer. Systematic review and meta-analysis","volume":"89","author":"Perletti","year":"2017","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.eururo.2023.04.021_b0665","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7150\/jca.37235","article-title":"Correlation between prostatitis, benign prostatic hyperplasia and prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0670","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1158\/1055-9965.EPI-19-0387","article-title":"A systematic review and meta-analysis of associations between clinical prostatitis and prostate cancer: new estimates accounting for detection bias","volume":"28","author":"Langston","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b0675","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s11255-021-02892-w","article-title":"Association between prostate size and the incidence of prostate cancer: a meta-analysis and review for urologists and clinicians","volume":"53","author":"Moolupuri","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2023.04.021_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sj\u00f6gren's syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis","volume":"21","author":"Zhong","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.eururo.2023.04.021_b0685","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.eururo.2023.04.021_b0690","article-title":"The causal relationships between extrinsic exposures and risk of prostate cancer: a phenome-wide Mendelian randomization study","volume":"12","author":"Gu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0695","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.18632\/oncotarget.23850","article-title":"Tooth loss and cancer risk: a dose-response meta analysis of prospective cohort studies","volume":"9","author":"Shi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2023.04.021_b0700","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.7150\/ijms.46812","article-title":"Potential risk of certain cancers among patients with periodontitis: a supplementary meta-analysis of a large-scale population","volume":"17","author":"Ma","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.eururo.2023.04.021_b0705","doi-asserted-by":"crossref","first-page":"e0195683","DOI":"10.1371\/journal.pone.0195683","article-title":"Is periodontitis a risk indicator for cancer? A meta-analysis","volume":"13","author":"Corbella","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2023.04.021_b0710","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1590\/s1677-5538.ibju.2020.0333","article-title":"Periodontal disease and the risk of prostate cancer: a meta-analysis of cohort studies","volume":"47","author":"Guo","year":"2021","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0715","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.4317\/medoral.24308","article-title":"Association between periodontal disease and prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Wei","year":"2021","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.eururo.2023.04.021_b0720","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.21037\/tau-20-1358","article-title":"Inflammatory bowel disease and risk of urinary cancers: A systematic review and pooled analysis of population-based studies","volume":"10","author":"Feng","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0725","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clinre.2019.07.003","article-title":"An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis","volume":"44","author":"Chen","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.eururo.2023.04.021_b0730","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/medicina56060285","article-title":"Incidence of prostate cancer in inflammatory bowel disease: a meta-analysis","volume":"56","author":"Carli","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.eururo.2023.04.021_b0735","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41391-019-0177-7","article-title":"The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis","volume":"23","author":"Ge","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0740","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/2090598X.2020.1761674","article-title":"Inflammatory bowel disease and prostate cancer risk: a systematic review","volume":"18","author":"Haddad","year":"2020","journal-title":"Arab J Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0745","doi-asserted-by":"crossref","first-page":"164","DOI":"10.21037\/tau-20-1020","article-title":"Does inflammatory bowel disease increase the risk of lower urinary tract tumors: a meta-analysis","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0750","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.dld.2021.01.018","article-title":"Inflammatory bowel diseases and the risk of adverse health outcomes: umbrella review of meta-analyses of observational studies","volume":"53","author":"Shen","year":"2021","journal-title":"Digest Liver Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0755","doi-asserted-by":"crossref","first-page":"337","DOI":"10.23736\/S0031-0808.21.04507-9","article-title":"Metabolic syndrome and risk of prostate cancer: a systematic review and meta-analysis","volume":"64","author":"Motterle","year":"2022","journal-title":"Panminerva Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0760","doi-asserted-by":"crossref","first-page":"e11771","DOI":"10.1097\/MD.0000000000011771","article-title":"Serum C-peptide concentration and prostate cancer: a meta-analysis of observational studies","volume":"97","author":"Guo","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b0765","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/pcan.2017.1","article-title":"Meta-analysis of metabolic syndrome and prostate cancer","volume":"20","author":"Gacci","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0770","first-page":"431","article-title":"Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen","volume":"31","author":"Harrison","year":"2020","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.eururo.2023.04.021_b0775","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41598-020-79345-4","article-title":"Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Burton","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2023.04.021_b0780","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/annonc\/mdx819","article-title":"Body mass index and 20 specific cancers: re-analyses of dose-response meta-analyses of observational studies","volume":"29","author":"Choi","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0785","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/ijc.31553","article-title":"Quantitative association between body mass index and the risk of cancer: a global Meta-analysis of prospective cohort studies","volume":"143","author":"Fang","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0790","doi-asserted-by":"crossref","first-page":"97584","DOI":"10.18632\/oncotarget.20930","article-title":"Body mass index and incidence of nonaggressive and aggressive prostate cancer: a dose-response meta-analysis of cohort studies","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2023.04.021_b0795","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/advances\/nmab153","article-title":"Body composition and prostate cancer risk: a systematic review of observational studies","volume":"13","author":"Purcell","year":"2022","journal-title":"Adv Nutr"},{"key":"10.1016\/j.eururo.2023.04.021_b0800","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13643-021-01606-8","article-title":"Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews","volume":"10","author":"Shi","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.eururo.2023.04.021_b0805","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.eururo.2023.04.021_b0810","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-020-01288-6","article-title":"Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0815","first-page":"1105","article-title":"Examining the relationship between diabetes and prostate cancer through changes in screening guidelines","volume":"31","author":"Miller","year":"2020","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.eururo.2023.04.021_b0820","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/s41416-021-01347-4","article-title":"Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium","volume":"124","author":"Amadou","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0825","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eururo.2023.04.021_b0830","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.numecd.2020.09.023","article-title":"Risk of cancer incidence and mortality associated with diabetes: a systematic review with trend analysis of 203 cohorts","volume":"31","author":"Ling","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0835","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diabet.2017.09.004","article-title":"Fasting blood glucose and risk of prostate cancer: a systematic review and meta-analysis of dose-response","volume":"44","author":"Jayedi","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.eururo.2023.04.021_b0840","doi-asserted-by":"crossref","first-page":"15375","DOI":"10.18632\/oncotarget.23841","article-title":"Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2023.04.021_b0845","doi-asserted-by":"crossref","first-page":"939","DOI":"10.21037\/tcr.2019.06.03","article-title":"No significant association between immunosuppression in solid organ transplantation and prostate cancer risk: a meta-analysis of cohort studies","volume":"8","author":"Bao","year":"2019","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.eururo.2023.04.021_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106094","article-title":"Antidiabetic medications and the risk of prostate cancer in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"177","author":"Cui","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.eururo.2023.04.021_b0855","doi-asserted-by":"crossref","first-page":"e14955","DOI":"10.1097\/MD.0000000000014955","article-title":"Metformin use and prostate cancer risk: a meta-analysis of cohort studies","volume":"98","author":"Feng","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b0860","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12885-017-3934-9","article-title":"Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0865","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/CEJ.0000000000000514","article-title":"Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies","volume":"29","author":"Wang","year":"2020","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2020.100840","article-title":"The impact of thiazolidinediones on the risk for prostate cancer in patients with type 2 diabetes mellitus: a review and meta-analysis","volume":"27","author":"Nath","year":"2021","journal-title":"Meta Gene"},{"key":"10.1016\/j.eururo.2023.04.021_b0875","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12894-018-0318-7","article-title":"Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies","volume":"18","author":"Cao","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.04.019","article-title":"Systematic review and meta-analysis of randomised controlled clinical trial evidence refutes relationship between pharmacotherapy with angiotensin-receptor blockers and an increased risk of cancer","volume":"64","author":"Datzmann","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0885","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.clinthera.2020.06.021","article-title":"Association between the overall risk of prostate cancer and use of calcium channel blockers: a systematic review and meta-analysis","volume":"42","author":"Yang","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.eururo.2023.04.021_b0890","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/jcpt.12673","article-title":"Calcium channel blockers and the incidence of breast and prostate cancer: a meta-analysis","volume":"43","author":"Thakur","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.eururo.2023.04.021_b0895","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/10600280221098121","article-title":"The risk for prostate cancer with calcium channel blockers: a systematic review, meta-analysis, and meta-regression","volume":"57","author":"Rotshild","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eururo.2023.04.021_b0900","doi-asserted-by":"crossref","first-page":"e28998","DOI":"10.1097\/MD.0000000000028998","article-title":"A meta-analysis of allopurinol therapy and the risk of prostate cancer","volume":"101","author":"Lai","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b0905","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00228-020-02927-8","article-title":"The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis","volume":"76","author":"Song","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.eururo.2023.04.021_b0910","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41391-021-00437-x","article-title":"The association between occupational asbestos exposure with the risk of incidence and mortality from prostate cancer: a systematic review and meta-analysis","volume":"25","author":"Godono","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b0915","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/19.086","article-title":"Prostate cancer and asbestos: a systematic review and meta-analysis","volume":"24","author":"Dutheil","year":"2020","journal-title":"Perm J"},{"key":"10.1016\/j.eururo.2023.04.021_b0920","doi-asserted-by":"crossref","first-page":"109787","DOI":"10.1016\/j.envres.2020.109787","article-title":"Relationship between exposure to mixtures of persistent, bioaccumulative, and toxic chemicals and cancer risk: a systematic review","volume":"188","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2020","journal-title":"Environ Res"},{"key":"10.1016\/j.eururo.2023.04.021_b0925","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.31955","article-title":"Work stress and the risk of cancer: a meta-analysis of observational studies","volume":"144","author":"Yang","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0930","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10408444.2018.1439449","article-title":"Exposure to permethrin and cancer risk: a systematic review","volume":"48","author":"Boffetta","year":"2018","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.eururo.2023.04.021_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105096","article-title":"Site-specific cancer risk following cobalt exposure via orthopedic implants or in occupational settings: a systematic review and meta-analysis","volume":"129","author":"Holy","year":"2022","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.eururo.2023.04.021_b0940","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2019.00024","article-title":"The effect of hexavalent chromium on the incidence and mortality of human cancers: a meta-analysis based on published epidemiological cohort studies","volume":"9","author":"Deng","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0945","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/ijc.32199","article-title":"Cancer incidence and mortality among firefighters","volume":"145","author":"Jalilian","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b0950","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12940-017-0336-z","article-title":"Prostate cancer in firefighting and police work: a systematic review and meta-analysis of epidemiologic studies","volume":"16","author":"Sritharan","year":"2017","journal-title":"Environ Health"},{"key":"10.1016\/j.eururo.2023.04.021_b0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106825","article-title":"Cancer incidence in agricultural workers: findings from an international consortium of agricultural cohort studies (AGRICOH)","volume":"157","author":"Togawa","year":"2021","journal-title":"Environ Int"},{"key":"10.1016\/j.eururo.2023.04.021_b0960","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.3390\/ijerph18084343","article-title":"Cancer incidence and mortality among petroleum industry workers and residents living in oil producing communities: a systematic review and meta-analysis","volume":"18","author":"Onyije","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eururo.2023.04.021_b0965","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/oemed-2021-107498","article-title":"Cancer and mortality in coal mine workers: a systematic review and meta-analysis","volume":"79","author":"Alif","year":"2022","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.eururo.2023.04.021_b0970","doi-asserted-by":"crossref","first-page":"91","DOI":"10.15430\/JCP.2019.24.2.91","article-title":"Occupational risk factors for prostate cancer: a meta-analysis","volume":"24","author":"Krstev","year":"2019","journal-title":"J Cancer Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b0975","doi-asserted-by":"crossref","first-page":"e8537","DOI":"10.1097\/MD.0000000000008537","article-title":"Shift work, night work, and the risk of prostate cancer: a meta-analysis based on 9 cohort studies","volume":"96","author":"Du","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b0980","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/carcin\/bgx129","article-title":"Association between shift work and risk of prostate cancer: a systematic review and meta-analysis of observational studies","volume":"39","author":"Gan","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.eururo.2023.04.021_b0985","first-page":"1","article-title":"Association between night-shift work and cancer risk: Updated systematic review and meta-analysis","volume":"10","author":"Dun","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b0990","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/ijerph17041345","article-title":"Shift work and prostate cancer: an updated systematic review and meta-analysis","volume":"17","author":"Rivera-Izquierdo","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eururo.2023.04.021_b0995","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jsxm.2018.07.004","article-title":"Sexual activity and risk of prostate cancer: a dose-response meta-analysis","volume":"15","author":"Jian","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2023.04.021_b1000","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.3390\/ijerph18168500","article-title":"Impact of sexual activity on the risk of male genital tumors: a systematic review of the literature","volume":"18","author":"Crocetto","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eururo.2023.04.021_b1005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/13685538.2018.1455178","article-title":"Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis","volume":"23","author":"Russo","year":"2020","journal-title":"Aging Male"},{"key":"10.1016\/j.eururo.2023.04.021_b1010","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3892\/ol.2017.6367","article-title":"Association between human papillomavirus and prostate cancer: a meta-analysis","volume":"14","author":"Yin","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.eururo.2023.04.021_b1015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13027-020-00305-8","article-title":"Evidence for a causal role by human papillomaviruses in prostate cancer\u2014a systematic review","volume":"15","author":"Lawson","year":"2020","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b1020","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/ajco.13124","article-title":"Association between human papillomavirus infection and prostate cancer: a global systematic review and meta-analysis","volume":"15","author":"Moghoofei","year":"2019","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b1025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13027-022-00427-1","article-title":"Multiple pathogens and prostate cancer","volume":"17","author":"Lawson","year":"2022","journal-title":"Infect Agent Cancer."},{"key":"10.1016\/j.eururo.2023.04.021_b1030","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/s41598-021-90404-2","article-title":"The association between hepatitis C virus infection and renal cell cancer, prostate cancer, and bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Ma","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2023.04.021_b1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103752","article-title":"Is there association between Trichomonas vaginalis infection and prostate cancer risk? A systematic review and meta-analysis","volume":"137","author":"Najafi","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.eururo.2023.04.021_b1040","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10654-021-00781-1","article-title":"Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium","volume":"36","author":"Salmon","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.eururo.2023.04.021_b1045","doi-asserted-by":"crossref","first-page":"e19486","DOI":"10.1097\/MD.0000000000019486","article-title":"Association of finasteride with prostate cancer: a systematic review and meta-analysis","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b1050","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.26452\/ijrps.v11i4.3860","article-title":"Effects of dutasteride on prostate cancer incidence: a systematic review and meta-analysis","volume":"11","author":"Min","year":"2020","journal-title":"Int J Res Pharm Sci"},{"key":"10.1016\/j.eururo.2023.04.021_b1055","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.21037\/tau-20-843","article-title":"Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis","volume":"9","author":"Hu","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1060","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1055-9965.EPI-21-1234","article-title":"5-Alpha reductase inhibitors and prostate cancer mortality among men with regular access to screening and health care","volume":"31","author":"Vaselkiv","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b1065","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jamaoncol.2022.1501","article-title":"Association of 5alpha-reductase inhibitors with prostate cancer mortality","volume":"8","author":"Bjornebo","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b1070","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12885-018-4156-5","article-title":"Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies","volume":"18","author":"Qiao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b1075","article-title":"Aspirin use and common cancer risk: a meta-analysis of cohort studies and randomized controlled trials","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b1080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.critrevonc.2018.09.013","article-title":"Effect of long term aspirin use on the incidence of prostate cancer: a systematic review and meta-analysis","volume":"132","author":"Sauer","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.eururo.2023.04.021_b1085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fonc.2018.00437","article-title":"Intake of non-steroidal anti-inflammatory drugs and the risk of prostate cancer: a meta-analysis","volume":"8","author":"Shang","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b1090","first-page":"8873","article-title":"The association of statin use with risk of kidney, bladder and prostate cancer: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Chen","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.eururo.2023.04.021_b1095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1159\/000518164","article-title":"Effect of statins on the risk of different stages of prostate cancer: a meta-analysis","volume":"106","author":"Li","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2023.04.021_b1100","doi-asserted-by":"crossref","first-page":"7827821","DOI":"10.1155\/2022\/7827821","article-title":"Association of statin use with the risk of incident prostate cancer: a meta-analysis and systematic review","volume":"2022","author":"Xu","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b1105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/jcm8060819","article-title":"Effect of statin on cancer incidence: an umbrella systematic review and meta-analysis","volume":"8","author":"Jeong","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.eururo.2023.04.021_b1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105522","article-title":"Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials","volume":"198","author":"Manson","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.eururo.2023.04.021_b1115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S149325","article-title":"Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies","volume":"14","author":"Gao","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.eururo.2023.04.021_b1120","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1158\/1055-9965.EPI-06-0357","article-title":"Cancer incidence and mortality and vitamin D in black and white male health professionals","volume":"15","author":"Giovannucci","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b1125","first-page":"1431","article-title":"The association between selenium and prostate cancer: a systematic review and meta-analysis","volume":"19","author":"Sayehmiri","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.eururo.2023.04.021_b1130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"301","author":"Lippman","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2023.04.021_b1135","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.purol.2018.07.004","article-title":"Association between phosphodiesterase type 5 inhibitors and prostate cancer: a systematic review","volume":"28","author":"Aoun","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2021.5866","article-title":"Association of spironolactone use with risk of cancer: a systematic review and meta-analysis","volume":"158","author":"Bommareddy","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.eururo.2023.04.021_b1145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12020-020-02376-4","article-title":"Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"70","author":"Lin","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.eururo.2023.04.021_b1150","doi-asserted-by":"crossref","first-page":"e13489","DOI":"10.1097\/MD.0000000000013489","article-title":"Is use of vitamin K antagonists associated with the risk of prostate cancer? A meta-analysis","volume":"97","author":"Luo","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eururo.2023.04.021_b1155","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/ijc.31886","article-title":"Use of vitamin K antagonists and risk of prostate cancer: meta-analysis and nationwide case-control study","volume":"144","author":"Kristensen","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b1160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1165","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Force","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2023.04.021_b1170","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djab072","article-title":"The impact of intensifying prostate cancer screening in Black men: a model-based analysis","volume":"113","author":"Nyame","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2023.04.021_b1175","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bju.14580","article-title":"Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial","volume":"123","author":"Pinsky","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.021_b1180","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/L17-0738","article-title":"Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials","volume":"168","author":"Tsodikov","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2023.04.021_b1185","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.eururo.2023.04.021_b1190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMc1807507","article-title":"MRI-targeted biopsy for prostate-cancer diagnosis","volume":"379","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.04.021_b1195","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/JU.0000000000000595","article-title":"Comparison of magnetic resonance imaging and transrectal ultrasound informed prostate biopsy for prostate cancer diagnosis in biopsy na\u00efve men: a systematic review and meta-analysis","volume":"203","author":"Goldberg","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.euo.2019.05.004","volume":"2","author":"Woo","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.021_b1205","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1186\/s12885-019-6434-2","article-title":"Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate cancer: a systematic review and meta-analysis","volume":"19","author":"Zhen","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2023.04.021_b1210","doi-asserted-by":"crossref","first-page":"e198427","DOI":"10.1001\/jamanetworkopen.2019.8427","article-title":"Comparison of multiparametric magnetic resonance imaging and targeted biopsy with systematic biopsy alone for the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"2","author":"Elwenspoek","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2023.04.021_b1215","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.04.021_b1220","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.04.021_b1225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/diagnostics8030057","article-title":"Promise and implementation of proteomic prostate cancer biomarkers","volume":"8","author":"Latosinska","year":"2018","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.eururo.2023.04.021_b1230","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2017.10.036","article-title":"Genomic markers in prostate cancer decision making","volume":"73","author":"Cucchiara","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1235","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2174\/0929867325666180914115416","article-title":"Novel diagnostic biomarkers of prostate cancer: an update","volume":"26","author":"Anceschi","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.eururo.2023.04.021_b1240","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.2147\/CMAR.S250829","article-title":"Biomarkers that differentiate benign prostatic hyperplasia from prostate cancer: a literature review","volume":"12","author":"McNally","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.eururo.2023.04.021_b1245","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.juro.2018.01.070","article-title":"Value of intact prostate specific antigen and human kallikrein 2 in the 4 kallikrein predictive model: an individual patient data meta-analysis","volume":"199","author":"Vickers","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1250","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.urology.2021.08.014","article-title":"Individual patient data meta-analysis of discrimination of the four kallikrein panel associated with the inclusion of prostate volume","volume":"157","author":"Vertosick","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.021_b1255","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","article-title":"Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2\u201310 ng\/ml: a multicentric European study","volume":"63","author":"Lazzeri","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1260","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.eururo.2017.03.025","volume":"72","author":"Klein","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40291-022-00584-4","article-title":"Proclarix, a new biomarker for the diagnosis of clinically significant prostate cancer: a systematic review","volume":"26","author":"Campistol","year":"2022","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.eururo.2023.04.021_b1270","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eururo.2017.12.028","article-title":"The Stockholm-3 model for prostate cancer detection: algorithm update, biomarker contribution, and reflex test potential","volume":"74","author":"Str\u00f6m","year":"2018","journal-title":"Eur Urol."},{"key":"10.1016\/j.eururo.2023.04.021_b1275","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.eururo.2018.08.019","article-title":"A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2\u201310 ng\/ml at initial biopsy","volume":"74","author":"McKiernan","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1280","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41391-021-00456-8","article-title":"Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies","volume":"25","author":"Margolis","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b1285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","article-title":"Urine TMPRSS2:ERG Plus PCA3 for individualized prostate cancer risk assessment","volume":"70","author":"Tomlins","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.021_b1290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41391-022-00538-1","article-title":"Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis","volume":"25","author":"Sari Motlagh","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2023.04.021_b1295","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajur.2021.06.003","article-title":"Blood and urine biomarkers in prostate cancer: are we ready for reflex testing in men with an elevated prostate-specific antigen?","volume":"8","author":"Chang","year":"2021","journal-title":"Asian J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823027860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823027860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:53:22Z","timestamp":1777550002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283823027860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":259,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0302283823027860"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2022 Update on Prostate Cancer Epidemiology and Risk Factors\u2014A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}